“We are going to Consider how the commercialization of the substance matches in with our company design at Adastra in an effort to position ourselves to help the need for a safe offer of copyright,” explained chief executive officer Michael Forbes within a news launch. The business instructed VICE Information it wouldn't be commenting more.Part